Publicaciones (94) Publicaciones de MARIA FERNANDEZ PRADA

2024

  1. COVID-19 InfoVaccines: A WHO-supported educational project to promote COVID-19 vaccination information among professionals and the general population

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. Cost–benefit analysis of the National Immunization Program in Spain

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  3. Decalogue of best practices in vaccine communication between immunocompromised patients and healthcare professionals

    Vacunas, Vol. 25, Núm. 3, pp. 420-423

  4. Guía de recomendaciones para la prevención de la infección sociosanitaria en las residencias de mayores

    Farmacéuticos comunitarios, Vol. 16, Núm. 1, pp. 28-50

  5. New COVID-19 vaccination recommendations in Spain: Optimizing for next seasons

    Enfermedades Infecciosas y Microbiologia Clinica

  6. Tixagevimab-cilgavimab as pre-exposure prophylactic treatment against SARS-CoV-2 in kidney transplantation patients

    Nefrologia

  7. Tixagevimab-cilgavimab as pre-exposure prophylactic treatment against SARS-CoV-2 in kidney transplantation patients

    Nefrologia, Vol. 44, Núm. 3, pp. 396-401

2023

  1. Executive summary - Diagnosis, treatment and prophylaxis of influenza virus infection – Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

    Anales de Pediatria, Vol. 98, Núm. 3, pp. 213-227

  2. Executive summary – Diagnosis, treatment and prophylaxis of influenza virus infection – Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

    Atencion Primaria, Vol. 55, Núm. 6

  3. Executive summary. Diagnosis, treatment and prophylaxis of influenza virus infection. Consensus statement of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC), the Spanish Society of Pediatric Infectious Diseases (SEIP), the Spanish Association of Vaccinology (AEV), the Spanish Society of Family and Community Medicine (SEMFYC) and the Spanish Society of Preventive Medicine, Public Health and Health Management (SEMPSPGS)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 2, pp. 111-122

  4. Infecciones asociadas a la atención sanitaria

    Conceptos de salud pública y estrategias preventivas: un manual para ciencias de la salud (Elsevier), pp. 256-265

  5. Influenza diagnosis, treatment and prophylaxis. Consensus statement

    Vacunas, Vol. 24, Núm. 2, pp. 81-83

  6. Preliminary evaluation of an inter-professional e-consultation on vaccines

    Journal of Telemedicine and Telecare, Vol. 29, Núm. 2, pp. 111-116

  7. Recommendations for the prevention of healthcare-associated infections in nursing homes

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 6, pp. 552-561

  8. Redefining the paradigm of immunization in immunocompromised post-pandemic patients

    Enfermedades Infecciosas y Microbiologia Clinica

  9. Resumen ejecutivo – Diagnóstico, tratamiento y profilaxis de la infección por virus de la Gripe – Documento de Consenso de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC), la Sociedad Española de Infectología Pediátrica (SEIP), la Asociación Española de Vacunología (AEV), la Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC) y la Sociedad Española de Medicina Preventiva, Salud Pública y Gestión Sanitaria (SEMPSPGS)

    Anales de Pediatría: Publicación Oficial de la Asociación Española de Pediatría ( AEP ), Vol. 98, Núm. 3, pp. 213-227

  10. Safety and immunogenicity of cilgavimab-tixagevimab for COVID-19 pre-exposure prophylaxis in immunocompromised patients

    Medicina Clinica, Vol. 160, Núm. 10, pp. 458-459

  11. The PHH-1V HIPRA vaccine: a new tool in the vaccination strategy against COVID-19

    Revista Espanola de Quimioterapia, Vol. 36, Núm. 5, pp. 507-515

2022

  1. Consensus statement on the use of alemtuzumab in daily clinical practice in Spain

    Neurologia, Vol. 37, Núm. 8, pp. 615-630

  2. Vesiculobullous skin reactions induced by COVID-19 mRNA vaccine: report of four cases and review of the literature

    Clinical and Experimental Dermatology